ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Presents at ASX Small & Mid-Cap Conference
|
|
vrs37
|
68 |
18K |
1 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
68
|
18K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Presents at ASX Small & Mid-Cap Conference
|
|
vrs37
|
68 |
18K |
0 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
68
|
18K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
4 |
608 |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
4
|
608
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Presents at ASX Small & Mid-Cap Conference
|
|
vrs37
|
68 |
18K |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
68
|
18K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
vrs37
|
48 |
13K |
0 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
48
|
13K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
vrs37
|
48 |
13K |
0 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
48
|
13K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
vrs37
|
48 |
13K |
0 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
48
|
13K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
vrs37
|
48 |
13K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
48
|
13K
|
1
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
11K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
44
|
11K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
vrs37
|
48 |
13K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
48
|
13K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
vrs37
|
629 |
200K |
0 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
629
|
200K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
vrs37
|
629 |
200K |
0 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
629
|
200K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
vrs37
|
629 |
200K |
2 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
629
|
200K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
vrs37
|
629 |
200K |
0 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
629
|
200K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
vrs37
|
629 |
200K |
2 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
629
|
200K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: AACR Conference Presentation
|
|
vrs37
|
7 |
1.2K |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
7
|
1.2K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: AACR Conference Presentation
|
|
vrs37
|
7 |
1.2K |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
7
|
1.2K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: AACR Conference Presentation
|
|
vrs37
|
7 |
1.2K |
2 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
7
|
1.2K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: AACR Conference Presentation
|
|
vrs37
|
7 |
1.2K |
4 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
7
|
1.2K
|
4
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
11K |
2 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
44
|
11K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vrs37
|
176 |
50K |
3 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
176
|
50K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vrs37
|
176 |
50K |
3 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
176
|
50K
|
3
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
11K |
0 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
44
|
11K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vrs37
|
176 |
50K |
5 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
176
|
50K
|
5
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vrs37
|
176 |
50K |
3 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
176
|
50K
|
3
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
11K |
0 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
44
|
11K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vrs37
|
176 |
50K |
3 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
176
|
50K
|
3
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
11K |
0 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
44
|
11K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vrs37
|
176 |
50K |
1 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
176
|
50K
|
1
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
11K |
2 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
44
|
11K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
11K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
44
|
11K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
11K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
44
|
11K
|
1
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
11K |
2 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
44
|
11K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
11K |
5 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
44
|
11K
|
5
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
11K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
44
|
11K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
14K |
0 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
58
|
14K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
22K |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
22K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
22K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
22K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
22K |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
22K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
22K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
22K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
22K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
22K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
22K |
2 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
22K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
22K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
22K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
22K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
22K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
22K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
22K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
22K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
22K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
22K |
2 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
22K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
14K |
0 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
58
|
14K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
14K |
0 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
58
|
14K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
14K |
1 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
58
|
14K
|
1
|
|